These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34597343)

  • 1. A new phenothiazine derivate is active against Clostridioides difficile and shows low cytotoxicity.
    Ronco T; Aragao FM; Saaby L; Christensen JB; Permin A; Williams AR; Thamsborg SM; Olsen RH
    PLoS One; 2021; 16(10):e0258207. PubMed ID: 34597343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 4. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
    Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.
    Louie TJ; Cannon K; Byrne B; Emery J; Ward L; Eyben M; Krulicki W
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S132-42. PubMed ID: 22752862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy Assessment of the Co-Administration of Vancomycin and Metronidazole in
    Zhong S; Yang J; Huang H
    J Microbiol Biotechnol; 2024 Apr; 34(4):828-837. PubMed ID: 38668685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
    Yamaguchi T; Konishi H; Aoki K; Ishii Y; Chono K; Tateda K
    J Infect Chemother; 2020 May; 26(5):483-491. PubMed ID: 32165071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
    Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of nisin on Clostridioides difficile and microbiota composition in a faecal fermentation model of the human colon.
    O'Reilly C; O'Connor PM; O'Sullivan Ó; Rea MC; Hill C; Ross RP
    J Appl Microbiol; 2022 Feb; 132(2):1397-1408. PubMed ID: 34370377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
    Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
    Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection.
    Zackular JP; Moore JL; Jordan AT; Juttukonda LJ; Noto MJ; Nicholson MR; Crews JD; Semler MW; Zhang Y; Ware LB; Washington MK; Chazin WJ; Caprioli RM; Skaar EP
    Nat Med; 2016 Nov; 22(11):1330-1334. PubMed ID: 27668938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
    Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.
    Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
    BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insoluble polysaccharides produced in plant cell cultures protect from Clostridioides difficile colitis.
    Bernabè G; Castagliuolo I; Porzionato A; Casarotto G; Monte RD; Carpi A; Brun P
    Microbiol Res; 2024 Sep; 286():127812. PubMed ID: 38954992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.